+358 4170 82703 [email protected]
The burden of AMR and the need for new antibiotics

The burden of AMR and the need for new antibiotics

Ville Kainu MD. PhD. Global Medical Affairs Director, Anti-Infectives Pfizer How to incentivize research and development A few years ago, the WHO developed a priority list of bacteria against which new antibiotics are needed, ranging from critical to medium priority....
Superbugs: A Global Health Threat

Superbugs: A Global Health Threat

Antibiotic-resistant bacteria are multiplying. To stop them, we must preserve the drugs we have—and find new antibiotics now. Mary Millard lives with an antibiotic-resistant infection, caused by bacteria known as Pseudomonas aeruginosa, that she acquired during...